Venus Concept Inc. (NASDAQ:VERO) shows a potential downside of approximately -25.65% in its stock price, indicating a pessimistic outlook from investment analysts.NanoVibronix, Inc. (NAOV) has a negative EPS of -51.81 and a PE ratio of -4.73, highlighting significant market challenges.Bone Biologics Corporation (BBLG) exhibits the highest growth potential among its peers with a price percentage difference of 9.32%, suggesting a more favorable market sentiment.Venus Concept Inc. (NASDAQ:VERO) operates in the ...